InQ Biosciences
Huntsville, Alabama, United States
About InQ Biosciences
InQ Biosciences Corporation provides integrated cell growth and cell analysis system that combines a software-controlled sample environment with imaging and real-time data collection for research and development in cell and tissue growth. Its InQ system offers simulation of the environment in the human body; precise management of temperature, gas levels, media perfusion, and pressure for extended cell growth; automated onboard microscopy with remote monitoring for cell analysis; and visualization. The company offers cell culture equipment for cell research fields; and InQ Cellular Research System, which creates an in vivo environment for studying sensitive human and animal cells for disease research. It serves neuroscience research, stem cell research, cancer biology research, and cardiovascular research applications
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 11 – 50
- Estimated revenue: $10K – $50K
- Total funding: $510.0K
- Last round: Series Unknown (Mar 2010)
- Website: inqbio.com
- Phone: 256-489-0318
Industries & Categories
Biotechnology, Developer Platform, Therapeutics
Social Profiles
Canonical: https://fsome.com/organization/inq-biosciences-2609198 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.